Insider · CIK 0001958857
Trafford Clarke
Files at TRAW (Traws Pharma, Inc.). First filing -, latest -.
In brief
Trafford Clarke files SEC Form 4 as director at TRAW (Traws Pharma, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Trafford Clarke has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | TRAW Traws Pharma, Inc. | AGrant or award Stock Option (right to buy)derivative | +14,150 | $0.00 | $0 | 14,150 | Jul 14, 2026 |
| Mar 8, 2026 | TRAW Traws Pharma, Inc. | AGrant or award Stock Option (right to buy)derivative | +33,435 | $0.00 | $0 | 33,435 | Mar 10, 2026 |
| Dec 12, 2025 | TRAW Traws Pharma, Inc. | AGrant or award Common Stock | +6,157 | $0.00 | $0 | 6,157 | Dec 16, 2025 |
| Dec 12, 2025 | TRAW Traws Pharma, Inc. | AGrant or award Stock Option (right to purchase)derivative | +24,629 | $0.00 | $0 | 24,629 | Dec 16, 2025 |
| Oct 12, 2025 | TRAW Traws Pharma, Inc. | AGrant or award Stock Option (right to purchase)derivative | +11,530 | $0.00 | $0 | 11,530 | Oct 15, 2025 |
| Jun 19, 2025 | TRAW Traws Pharma, Inc. | AGrant or award Stock Option (right to purchase)derivative | +23,000 | $0.00 | $0 | 23,000 | Jun 23, 2025 |
Questions about Trafford Clarke
Answered from the filings on this page, as of the latest one.
Is Trafford Clarke buying or selling?
Trafford Clarke has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Trafford Clarke's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Trafford Clarke has 0.
Where does Trafford Clarke file Form 4?
Trafford Clarke has filed Form 4 at TRAW (Traws Pharma, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.